Electronic System Reminds Patients to Schedule Exams

News
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 4
Volume 16
Issue 4

A computerized mail and phone reminder program managed by appointment secretaries significantly increased the percentage of patients undergoing annual mammography at the Mayo Clinic

ROCHESTER, Minnesota—A computerized mail and phone reminder program managed by appointment secretaries significantly increased the percentage of patients undergoing annual mammography at the Mayo Clinic, according to a study by Rajeev Chaudhry, MBBS, MPH, and colleagues (Arch Intern Med 167:606-611, 2007).

The researchers randomized 6,665 women age 40 to 75 to usual care or to an intervention group that received mailings (two monthly letters starting 3 months before they were due for screening) followed by a phone call to nonresponding patients, to remind them to schedule a mammogram.

Among the reminded group, 64.3% had their annual mammogram vs 55.3% of controls (P < .001). There were no significant differences between the two groups for any of the other adult preventive services. A subgroup that also received an email reminder had a 72.2% compliance rate. As the program has expanded following the study period, compliance has now grown to more than 72%, Dr. Chaudhry said, with 86% having had one exam within the previous 2 years.

Recent Videos
Trials at scale can be conducted in middle-income, low-middle-income, and even lower-income countries if you organize a trial ecosystem.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
A consolidated database may allow providers to access information on a patient’s prior treatments and genetic abnormalities all in 1 place.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Related Content